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Second Department of Internal Medicine, 2) Department of Laboratory Medicine, and Science, Nagasaki, Japan 3 resistance (9, 11, 16, 23) . This current method could identify simultaneously both the gyrA and the parC mutations by only one PCR performance.
Seventeen H. influenzae clinical isolates were used. Ten of the strains were susceptible to FQ, and seven of the strains had low susceptibility or were resistant to FQ. The seven FQ resistant/low susceptibility strains were: 1 strain (NUH-1) from Nagasaki University Hospital, 1 strain (BY-1) from Bayer (Osaka, Japan), 2 strains (DR-1, DS-2) from Daiichi-Sankyo (Tokyo, Japan), and 3 strains (MSC24060, MSC27995, MSC11438) kindly provided by Meiji-Seika Kaisha (Tokyo, Japan) (21) . The 10 FQ-susceptible strains were isolated at Nagasaki University Hospital. Identification of H. influenzae was confirmed by colony morphology, Gram staining, growth on chocolate agar, and the X and V factor requirement. The minimum inhibitory concentrations (MICs) of ciprofloxacin (CPFX), sparfloxacin (SPFX), levofloxacin (LVFX), gatifloxacin (GTFX), moxifloxacin (MXFX), garenoxacin (GRNX), and sitafloxacin (STFX) were determined by a broth dilution method using Haemophilus test medium according to the recommendations of the Clinical and Laboratory Standards Institute (CLSI) (5) . H. influenzae ATCC51907 was used for quality control. μM concentration of each probe, and a 0.5 μM concentration of each primer. Thermal cycling was performed with an initial hold for 5 min at 95°C, followed by 30 cycles of 10 s at 95°C, 10 s at 58°C, and 12 s at 72°C. A melting curve was generated by cooling the reaction mixture to 35°C for 10 s, followed by heating to 90°C at a rate of 0.2°C/s.
The PCR-MCA assay was performed using LightCycler 480 Basic software (Roche Diagnostics, Basel, Switzerland). The total assay time was approximately 1 h. The QRDR DNA sequencing results were compared with the sequence of strain Rd (GenBank accession no. NC000907), which was used as the wild-type standard strain.
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Using specific probes for the wild-type strain, all of the mutant strains showed characteristic melting peaks with a distinct T m value, as shown in Figure 1 . The minimum T m shifts for mutant strains compared to the wild-type strain were 6.13°C for parC codons 84 and 88, 11.58°C for gyrA codon 84, and 7.9°C for gyrA codon 88. The PCR-MCA assay correctly detected seven LVFX low susceptibility/resistant strains, as determined by a comparison with sequencing results (Table 2) . From sequencing results, all seven FQ low susceptibility/resistant strains had at least two single amino acid substitutions at four QRDR positions (Table 3 ). All LVFX-susceptible H. influenzae strains had the same T m value as the wild-type strain, and sequencing results confirmed that these were in fact wild-type strains (data not shown).
We compared the ability of the present PCR-MCA assay to detect FQ susceptibility in seventeen H. influenzae strains with that of the conventional phenotypic method. All LVFX-susceptible strains which had no mutation in condons 84 and 88 of gyrA and parC classified susceptible according to CLSI criteria (6) (data not shown). As shown in Table 3 , the mutation profiles for the QRDRs in the gyrA and parC revealed a close relationship between the MIC level and the number of QRDR mutations. Previous studied have found that the conventional phenotypic method failed to detect strains that have a single QRDR mutation; these strains have the potential to develop into a highly 6 resistant pathogen (7) . Several reports have noted that a significant number of Streptococcus pneumoniae isolates already have a single step mutation, and prone to acquiring second step mutation (19) . Unfortunately, our study lacks a collection of single-mutant strains. It was reported that the selection window for ciprofloxacin with wild-type cells was below serum drug concentrations in human volunteers administered twice-daily of 500mg (10 reported the stepwise selection of ciprofloxacin-resistant H. influenzae mutants and could be the high level resistant strain (12) . Increasing the time that drug concentration fall into the mutant selection window causes the mutation (8) . Actually, the previously reported strains that failed treatment had a double mutant in the gyrA and the parC (2).
We emphasize the clinical importance of the detection of first-step QRDR mutations in either gyrA or parC for attempting to predict evolution into FQ resistance. In addition, we should consider the FQ dosage carefully to avoid the low FQ concentration when we treat the patients who have chronic lung disease.
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In conclusion, the PCR-MCA assay was easily and quickly performed and had an accuracy that was at least as satisfactory as that of the conventional phenotypic method.
FQ-resistant H. influenzae is expected to become a more important pathogen in the future, because FQ is the most effective antibiotic against H. influenzae, and the number of FQ-resistant strain may arise further along with the recent increase of FQ prescription.
Although additional studies are need, we anticipate that this PCR-MCA assay may be a useful tool for surveillance studies in the screening of FQ resistance as an alternative to DNA nucleotide sequencing because this PCR-MCA assay can recognize the gyrA and the parC mutants more clearly, easily and rapidly than sequencing. 
